# Project Governance Framework
## NIW Evidence: Systems Management & Project Leadership

## Executive Oversight Structure
**Governance Model**: Founder-Led with Advisory Board
**Decision Rights**: Strategic (Founder) vs Operational (Team Leads)
**Reporting Structure**: Agile with 2-week sprint cycles

## Strategic Control Points
| Control Point | Frequency | Metrics | Decision Authority |
|---------------|-----------|---------|-------------------|
| **Budget Review** | Monthly | Burn rate, ROI projections | Founder + Finance Lead |
| **Technical Milestones** | Bi-weekly | Feature completion, QA metrics | CTO + Product Lead |
| **Regulatory Compliance** | Monthly | FDA timeline, documentation status | Founder + Compliance Lead |
| **Clinical Outcomes** | Quarterly | A1C reduction, patient engagement | Clinical Lead |

## Performance Management Framework
### Key Performance Indicators (KPIs)
**Business KPIs:**
- Monthly Burn Rate: < $20,000 (Phase 1)
- Grant Funding Secured: $355,000 target
- Patient Acquisition Cost: < $50/patient

**Clinical KPIs:**
- A1C Reduction: 0.8-1.0% target
- Patient Engagement: >80% response rate
- System Uptime: 99.9% SLA

**Regulatory KPIs:**
- FDA Q-Sub Meeting: Month 3
- eSTAR Completion: Month 6
- 510(k) Submission: Month 9

## Communication Protocol
**Internal Reporting:**
- Team Standups: Daily (15 mins)
- Sprint Reviews: Bi-weekly
- Leadership Meetings: Weekly

**External Reporting:**
- Investor Updates: Monthly
- Regulatory Submissions: As required by FDA
- Grant Reporting: Per funding requirements

## Change Management Process
1. **Change Request** → Document impact on timeline/budget
2. **Stakeholder Review** → Clinical, technical, regulatory assessment
3. **Approval Gate** → Founder approval for strategic changes
4. **Implementation** → Updated project plan and communications
